首页 | 本学科首页   官方微博 | 高级检索  
     

盆腔脏器联合切除治疗泌尿系肿瘤
引用本文:廖文峰,马潞林,汪欣. 盆腔脏器联合切除治疗泌尿系肿瘤[J]. 中国医学文摘(检验与临床), 2012, 0(3): 132-134
作者姓名:廖文峰  马潞林  汪欣
作者单位:[1]北京大学第三医院泌尿外科,100191 [2]北京大学第一医院普通外科,100191
摘    要:目的探讨盆腔脏器联合切除术在治疗泌尿系肿瘤中的作用。方法对行联合脏器切除的9例泌尿系肿瘤患者(包括前列腺肉瘤术后复发1例、前列腺肉瘤术后胃肠道间质瘤转移1例、前列腺肉瘤1例、前列腺癌术后复发1例、宫颈癌术后复发1例、膀胱肉瘤1例、直肠癌术后复发3例)进行回顾性分析。结果 8例接受全盆腔脏器切除术,1例为根治性膀胱前列腺切除。无围手术期死亡,术后并发症发生率100%。随访至今,3例健在,平均生存时间26.8(5~64)个月。结论盆腔脏器联合切除可有效地治疗周围脏器受侵犯的泌尿系肿瘤,改善患者预后,提高生活质量,但术后并发症较多。患者预后主要与原发肿瘤病理类型有关。

关 键 词:盆腔脏器联合切除  泌尿系肿瘤  治疗

Pelvic exenteration for tumors of the urinary syste
LIAO Wen-feng,MA Lu-lin,WANG Xin. Pelvic exenteration for tumors of the urinary syste[J]. , 2012, 0(3): 132-134
Authors:LIAO Wen-feng  MA Lu-lin  WANG Xin
Affiliation:.Department of Urology, Peking University Thr-d Hospital, Beijing 100191 , China
Abstract:Objective To discuss the treatment meaning of the pelvic exenteration for the genito-urinary tumors. Methods Clincal datas of 9 patients who underwent pelvic exenteration were analyzed retrospectively (2 prostate sarcoma, 1 bladder leiomyosarcoma, 1 relapse prostate cancer, 1 gastrointestinal stromal tumor, 1 cervical cancer, 3 relapse rectal cancer). Results 8 patients underwent total pelvic exenteration, 1 eystoprostatectomy. No perioperatipn death. All pa- tients had postoperation complications. The mean survival time was 26.8 (5-64) r~onths, 3 still a- live. Conclusions Pelvic exenteration can be used to treat the genito-urinary tum~)rs which invade the surrounding organs, prolonging survive time, improving quality of life, but there are more posts- urgieal complications. The prognosis is mainly related to the pathology of the primary tumor.
Keywords:Pelvic exenteration  Urologic neoplasms  Therapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号